Circulation of progenitor cells after intensive chemotherapy followed by combination G-CSF and EPO in breast carcinoma

Neoplasma

Volumn 44, Issue 4, 1997, Pages 212-218

  Filip, S ^a   Vanasek J ^a   Blaha M ^a   Vavrova J ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b DEPARTMENT OF TOXICOLOGY   (Czech Republic)

Author keywords

Breast carcinoma; G CSF and EPO; Intensive chemotherapy; Progenitor cells

Indexed keywords

CYCLOPHOSPHAMIDE; EPIRUBICIN; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ANEMIA; ARTICLE; BLOOD TRANSFUSION; BREAST CARCINOMA; BURST FORMING UNIT E; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COLONY FORMING UNIT GM; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEMATOPOIESIS; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUTROPENIA; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0030847972     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. BESSOHO, M., TOYODA, A., ITHO, Y. et al.: Trilineage recovery by combination with recombinant human granulocyte colony-stimulating factor (rhG-CSF) and erythropoietin (rhEpo) in severe aplastic anemia. Br. J. Haematol., 80, 1992, 409-411.
2. BREGNI, M., SIENA, S., DI NICOLA, M. et al. Comparative effects of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor after high-dose cyclophosphamide cancer therapy. J. Clin. Oncol., 14, 1996, 628-635.
3. CARO, J., ERSLEV, A.: Erythropoietin assays and their use in the study of anemias. Contr. Nephrol., 66, 1988, 54-62.
4. DESSYPRIS, E.N., GRABER, S.E., KRANZ, S.B., STONE, W.J.: Effects of recombinant erythropoietin on the concentration and cycling status of human marrow hematopoietic progenitor cells in vivo. Blood, 72, 1988, 2060-2062.
5. CHAO, N.J. et al.: A randomized study of erythropoietin and granulocyte colony-stimulating factors (G-CSF) versus placebo and G-CSF for patients with Hodgkin's and non-Hodgkin's lymphoma undergoing autologous bone marrow transplantation. Blood, 83, 1994, 2823-2828.
6. GABRILOVE, J.L., JAKUBOWSKI, A.: Granulocyte colony-stimulating factor: Preclinical and clinical studies. Hematol. Oncol. Clin. North Am., 3, 1989, 427-440.
7. GABRILOVE, J.L.: Introduction and overview of hematopoietic growth factors. Semin. Hematol., Suppl. 2, 26, 1989, 1-4.
8. GANSER, M., BERGMANN, M., VOLKERS, B. et al.: In vivo effects of recombinant human erythropoietin on circulatin human hemopoietic progenitor cells. Exp. Hematol., 17, 1989, 433-435.
9. GIANNI, A.M., SIENA, S., BREGNI, M. et al., Granulocyte-macrophage colony-stimulating factor to harvest circulating hemopoetic stem cells for autotransplantation. Lancet, 2, 1989, 580-585.
10. GERHARTZ, H.H., STERN, A.C., WOLF-HORNUNG, B. et al.: Treatment of neutropenia in patients undergoing cancer chemotherapy. In: Molgramostim GM-CSF: Possibilities and Perspectives. Ed.: Gorin, N.C. Oxford, Alden Press 1992, 27-41.
11. HAAS, R., HOHAUS, S., EGERER, G. et al.: Recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) subsequent to chemotherapy improves collection of blood stem cells for autografting in patients not eligible for bone marrow harvest. Bone Marrow Transplant., 9, 1992, 459-465.
12. HENON, P.R.: Comparative cost analysis of autologous blood cell transplantation and autologous bone marrow transplantation. Blood, Suppl. 1, 84, 1994.
13. HINO, M., MIYAZONO, K., URABE, A., TAKAKU, F.: Effect of recombinant human erythropoietin on hematopoietic progenitors of chronic hemodialysis patients in vitro and in vivo. Int. J. Cell. Cloning, 7, 1989, 257-262.
14. ISHIBASHI, T., KOZIOL, J.A., BURNESTEIN, S.A.: Human recombinant erythropoietin promotes differentiation of murine megakaryocyte in vitro. J. Clin. Invest., 79, 1987, 286-289.
15. KESSINGER, A., BISHOP, M., JACKSON, J. et al.: Erythropoietin for mobilization of circulating progenitor cells. Abstract. In: 3rd International Symposium on Peripheral Blood Stem Cell Autografts, Bordeaux, France, 1993.
16. LAVER, J., MOORE, M.A.S.: Clinical use of recombinant human hematopoietic growth factors. J. Natl. Cancer Inst., 81, 1989, 1370-1382.
17. LUDWIG, H., FRITZ, E., LEITGEB, C. et al.: Erythropoietin treatment for chronic anemia of selected hematological malignancies and solid tumors. Ann. Oncol., 4, 1993, 161-167.
18. MAJUMDAR, G., WESTWOOD, N.B., BELL-WITTER, C. et al.: Serum erythropoietin and circulating BFU-E in patients with multiple myeloma and anemia but without renal failure. Leukemia Lymphoma, 9, 1993, 173-176.
19. MARTIN, E. et al.: Primary structure and functional expression of rat and human stem cell factor DNAs. Cell, 63, 1990, 203-207.
20. MILES, S.A. et al.: Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hematologic toxicity from zidovudine. Blood, 77, 1991, 2109-2117.
21. MILES, S.A.: The use of hemopoietic growth factors in HIV infection and AIDS-related malignancies. Cancer Invest., 9, 1991, 229-238.
22. MORSTYN, G., DEXTER, M.T.: Filgrastim in Clinical Practice. New York, Marcel Dekker Inc. 1994, 351.
23. OLIVIERI, A., OFFIDANI, M., CANTORI, L. et al.: Addition of crythropoictin to granulocyte colony-stimulating factor after priming chemotherapy enchances hemopoietic progenitor mobilization. Bone Marrow Transplant., 16, 1995, 765-770.
24. OSSENKOPPELE, G.J., JONKHOFF, A.R., HUIJGENS, P.C. et al.: Peripheral blood progenitors mobilized by G-CSF and reinfused an unprocessed autologous whole blood shorten a pancytopenic period following high-dose melphalan in multiple myeloma. Bone Marrow Transplant., 13, 1994, 37-41.
25. OSTER, W., HERRMANN, F., GAMM, H. et al.: Erythropoietin for the treatment of anemia of malignancy associated with neoplastic bone marrow infiltration. J. Clin. Oncol., 8, 1990, 956-962.
26. PETERS, W.D., ROSNER, G., ROSS, M. et al.: Comparative effects of granulocyte-macrophage colony stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood, 81, 1993, 1709-1719.
27. PETTENGEL, R., WOLL, P.J., CHANG, J. et al.: Effect of erythropoietin on mobilization of hemopoietic progenitor cells. Bone Marrow Transplant., 14, 1994, 125-130.
28. PIERELLI, L., MENICHELLA, G., SCAMBIA, G. et al.: In vitro and in vivo effects of recombinant human erythropoietin plus recombinant human G-CSF on human hemopoietic progenitor cells. Bone Marrow Transplant., 14, 1994, 23-30.
29. POTHIER, O.N. et al.: IL-3 inhibits the binding of GM-CSF to AML blasts, but the two cytokines act synergistically in upporting blast proliferation. Leukemia, 4, 1990, 329-336.
30. ROB, P.M., WIEDEMANN, G.J., JELKMANN, W.: Proliferating erythrocytic progenitor cells may lower the blood level of erytropoietin by a negative feedback mechanism. Erythropoiesis: New dimensions in the treatment of anemia. 5, 1994, 21-24.
31. SHERIDAN, W.P., BEGLEY, C.G., JUTTNER, C.A. et al.: Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, 1992, 640-644.
32. SIENA, S., BREGNI, M., BRANDO, M. et al.: Circulation of CD34+ hematopoietic stem cells in the peripheral blood of high-dose cyclophosphamide-treated patients: Enhancement by intravenous recombinant human granulocyte-macrophage colony stimulating factor. Blood, 74, 1989, 1905-1914.
33. SHERIDAN, W.P., MORSTYN, G., WOLF, M. et al.: Granulocyte colony stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet, 2, 1989, 891-895.
34. SHERIDAN, W.P.: The role of colony-stimulating factors in bone marrow transplantation. Cancer Invest., 9, 1991, 221-228.
35. SHERIDAN, W.P., BEGLEY, C.G., JUTTNER, C.A. et al.: Effect of peripheral-blood progenitor cells mobilized by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet, 339, 1992, 640-644.
36. SCHRIBER, J.R., NEGRIN, R.S.: Use and toxicity of the colony stimulating factors. Drug Safety, 8, 1993, 457-468.
37. STOKENHUBER, F. et al.: Recombinant human erythropoietin activates a broad spectrum of progenitor cells. Kidney Int., 37, 1990, 150-156.
38. THOMSON, A.W. et al.: The Cytokine Handbook. London, Academic Press 1991, 419.
39. TRILLET, L.V., GREEN, J., MANEGOLD, J. et al.: Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur. J. Cancer, 29A, 1993, 319-324.
40. UYL-DE GROOT, C.A., OSSENKOPPELE, G.J., VAN RIET, A.A.P.M., RUTTEN, F.F.H.: The cost of peripheral blood progenitor cell reinfusion mobilized by granulocyte colony-stimulating factor following high dose melphalan as compared with conventional therapy in multiple myeloma.Eur.J.Cancer, 30A, 1994, 457-459.